A carregar...
Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
OBJECTIVE: To examine the effects of treatment with belimumab on corticosteroid dose in patients with systemic lupus erythematosus (SLE) over 52 weeks in 2 randomized, controlled trials. METHODS: Data on patients who were taking corticosteroids at baseline in the Study of Belimumab in Subjects with...
Na minha lista:
| Publicado no: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5129492/ https://ncbi.nlm.nih.gov/pubmed/26992106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39682 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|